ReviewJournal of cancer education : the official journal of the American Association for Cancer Education2025
Cancer Education Status in China (2013-2022).
Review in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative analysis of early-onset and late-onset esophageal cancer burden in China, 1990-2021: based on the 2021 Global Burden of Disease Study.Esophagus : official journal of the Japan Esophageal Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The incidence and mortality rates of cancer in China have an increasing trend, with a remarkable rise in the number of new cases and deaths. Despite this, cancer profile and regional distribution remained relatively stable. China realized a series of initiatives and issued strategic documents to improve cancer education. These include the establishment of a three-tier cancer prevention program and the fulfillment of various guidelines and plans, including the Healthy China Action-Cancer control Implementation Plan (2019-2022). This comprehensive review describes the status of cancer education in China from 2013 to 2022 discussing the role of different cancer education places and that of educators. It also highlights the use of innovative educational methods and educational evaluations, which are effective in improving patient outcomes and satisfaction. Although the Chinese government has taken many measures to improve cancer education in China, several issues remain unresolved. Challenges such as the wide spectrum of tumors, the aging population, and the huge urban-rural disparities require further investment from Chinese government. In addition, cancer control in China started relatively late and lacks the support of specific legislation to control it. It is therefore necessary to increase the investment in cancer education, especially in rural areas and the legislation in areas related to cancer control should be improved to increase the accessibility and quality of education on tumor prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.